My. Zhu et al., DOWN-REGULATION OF THE HUMAN NOREPINEPHRINE TRANSPORTER IN INTACT 293-HNET CELLS EXPOSED TO DESIPRAMINE, Journal of neurochemistry, 70(4), 1998, pp. 1547-1555
The effects of continuous exposure of cultured cells expressing the hu
man norepinephrine transporter (hNET) to the hNET inhibitor desipramin
e on hNET expression and function were studied. Exposure of HEK-293 ce
lls transfected stably with the hNET cDNA (293-hNET cells) to desipram
ine for 3 days reduced the specific binding of [H-3]nisoxetine in memb
rane homogenates in a concentration-dependent manner. The magnitude of
the reductions in [H-3]nisoxetine binding to hNET was dependent on th
e length of time of the exposure to desipramine, reaching 77% after a
21-day exposure, The reduction of [H-3]nisoxetine binding returned to
control levels within 72 h after a 3-day exposure to desipramine. Redu
ctions in [H-3]nisoxetine binding to hNET were accompanied by time-dep
endent and exposure concentration-dependent reductions in hNET protein
levels as determined by western blotting. Similar to binding, hNET pr
otein levels returned to control levels 72 h after cessation of desipr
amine exposure. Northern blotting indicated that exposure of 293-hNET
cells to desipramine did not significantly alter hNET mRNA levels. Upt
ake of [H-3]norepinephrine by 293-hNET cells was markedly reduced afte
r a 3-day exposure to desipramine. However, desipramine exposure had n
o effect on uptake of [H-3]glutamate or [H-3]alanine. The present find
ings imply that down-regulation of the hNET in 293-hNET cells induced
by desipramine results from a selective reduction in hNET protein leve
ls, presumably a consequence of either a reduction in the translation
of hNET mRNA or from an enhanced degradation of hNET protein.